Phase 2: Cooled focal therapy shows 88% success in #prostatecancer at 12 mo. 🔬
• No urinary incontinence 📊
• 100% potency retention
• High QoL profile
Via @bjuijournal.bsky.social @renalurologynews.bsky.social.
Read more: https://bit.ly/4cB2rF9
#GUsm #MedEd #Oncology #pcsm